These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33426593)

  • 21. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
    Kai H; Kai M
    Hypertens Res; 2020 Jul; 43(7):648-654. PubMed ID: 32341442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
    Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
    Chen L; Li X; Chen M; Feng Y; Xiong C
    Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, Transmission, and Molecular Immunopathology of SARS-CoV-2.
    Mallick R; Duttaroy AK
    Adv Exp Med Biol; 2021; 1352():33-44. PubMed ID: 35132593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It.
    Ahmad Malik J; Ahmed S; Shinde M; Almermesh MHS; Alghamdi S; Hussain A; Anwar S
    Saudi J Biol Sci; 2022 May; 29(5):3586-3599. PubMed ID: 35165505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down.
    Manolis AS; Manolis TA; Manolis AA; Melita H
    Curr Opin Cardiol; 2021 Mar; 36(2):241-251. PubMed ID: 33395080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19.
    Vitiello A; Ferrara F
    Life Sci; 2020 Dec; 262():118510. PubMed ID: 32991879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin Converting Enzyme-2 (ACE-2) role in disease and future in research.
    Abdul-Hafez A; Mohamed T; Uhal BD
    J Lung Pulm Respir Res; 2021; 8(2):54-60. PubMed ID: 34414260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do compromised mitochondria aggravate severity and fatality by SARS-CoV-2?
    Sharma NK; Sarode SC
    Curr Med Res Opin; 2022 Jun; 38(6):911-916. PubMed ID: 35403526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alveolar macrophages: Achilles' heel of SARS-CoV-2 infection.
    Wang Z; Li S; Huang B
    Signal Transduct Target Ther; 2022 Jul; 7(1):242. PubMed ID: 35853858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 and comorbidities: Deleterious impact on infected patients.
    Ejaz H; Alsrhani A; Zafar A; Javed H; Junaid K; Abdalla AE; Abosalif KOA; Ahmed Z; Younas S
    J Infect Public Health; 2020 Dec; 13(12):1833-1839. PubMed ID: 32788073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypokalaemic Paralysis Associated with COVID-19 Infection.
    Kaushik A; Garg A; Singh BM; Agarwal AK; Wani SN
    J Assoc Physicians India; 2021 Jan; 69(1):78-79. PubMed ID: 34227783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathomechanisms of SARS-CoV-2 infection and development of atherosclerosis in patients with COVID-19: A review.
    Gospodarczyk AZ; Wojciechowska C; Marczewski KP; Gospodarczyk NJ; Zalejska-Fiolka J
    Medicine (Baltimore); 2022 Dec; 101(49):e31540. PubMed ID: 36626452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin Angiotensin System and COVID-19 Infection.
    Ferrara F; Vitiello A
    Adv Pharm Bull; 2022 Jan; 12(1):1-4. PubMed ID: 35517880
    [No Abstract]   [Full Text] [Related]  

  • 39. A critical review on brain and heart axis response in COVID-19 patients: Molecular mechanisms, mediators, biomarkers, and therapeutics.
    Abha Mishra KM; Podili R; Pathlavath TS; Sethi KK
    J Biochem Mol Toxicol; 2023 Aug; 37(8):e23409. PubMed ID: 37341157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The elderly at risk: aldosterone as modulator of the immune response to SARS-CoV-2 infection.
    Campana P; Palaia ME; Conte M; Cante T; Petraglia L; Femminella GD; Parisi V; Leosco D
    Geroscience; 2022 Apr; 44(2):567-572. PubMed ID: 34741250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.